Matches in Wikidata for { <http://www.wikidata.org/entity/Q99563531> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- Q99563531 description "artículu científicu espublizáu en setiembre de 2020" @default.
- Q99563531 description "scientific article published on 17 September 2020" @default.
- Q99563531 description "wetenschappelijk artikel" @default.
- Q99563531 description "наукова стаття, опублікована 17 вересня 2020" @default.
- Q99563531 name "Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trial" @default.
- Q99563531 name "Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trial" @default.
- Q99563531 type Item @default.
- Q99563531 label "Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trial" @default.
- Q99563531 label "Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trial" @default.
- Q99563531 prefLabel "Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trial" @default.
- Q99563531 prefLabel "Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trial" @default.
- Q99563531 P1433 Q99563531-E7E1970A-EE68-4B96-B75B-0FF4AA28E07F @default.
- Q99563531 P1476 Q99563531-D9DD19CE-0A5D-4947-944A-CBC8339C51FB @default.
- Q99563531 P2093 Q99563531-05A44989-5B26-4445-810B-0D8D05DB3B35 @default.
- Q99563531 P2093 Q99563531-06042A24-D73C-424E-BE9D-00D090B0F0AF @default.
- Q99563531 P2093 Q99563531-06EDA9CA-6C76-4D9E-8C23-15385707F078 @default.
- Q99563531 P2093 Q99563531-0D404D96-E9D4-4DD2-B8ED-72C465E6D874 @default.
- Q99563531 P2093 Q99563531-102CEF83-3125-4802-9091-77E728D3F764 @default.
- Q99563531 P2093 Q99563531-10AA1B05-3217-40FE-B890-491C769095CC @default.
- Q99563531 P2093 Q99563531-10F39114-2FCB-4D64-9753-7407EB934DD5 @default.
- Q99563531 P2093 Q99563531-1F2DCC72-0A27-4811-8A39-2A877C7CC697 @default.
- Q99563531 P2093 Q99563531-44F3898B-83E2-43F5-958D-F6FF4BE102F9 @default.
- Q99563531 P2093 Q99563531-55C4FF20-D566-4D30-92AC-997597DA0E07 @default.
- Q99563531 P2093 Q99563531-6090F916-16B3-4EF8-985D-54AF0C68F238 @default.
- Q99563531 P2093 Q99563531-90C636C3-AB61-45CA-BA07-64A89D9D3E08 @default.
- Q99563531 P2093 Q99563531-99355D74-7441-438E-92D9-CD6192D2301A @default.
- Q99563531 P2093 Q99563531-9F3F7E2C-8C0C-4195-9C61-54821632D0F2 @default.
- Q99563531 P2093 Q99563531-A1486351-DEED-42E8-985F-4A1A25A033E3 @default.
- Q99563531 P2093 Q99563531-A23D320E-1675-4A9A-8390-A1D1CEAC4CF2 @default.
- Q99563531 P2093 Q99563531-AA2FE8FD-A3E2-47C2-AA75-F0C6A95E3CAB @default.
- Q99563531 P2093 Q99563531-C16CB5F7-CEC5-4E8D-949A-4D96206BE9A5 @default.
- Q99563531 P2093 Q99563531-D2C38AE3-5E9F-4707-B31A-DE309292A27F @default.
- Q99563531 P2093 Q99563531-D3C1A9C2-FF95-4E60-8EC2-6296C5D29989 @default.
- Q99563531 P2093 Q99563531-D776DC92-53AB-49D6-9173-A7F30D0E5BA5 @default.
- Q99563531 P2093 Q99563531-FF40DFEC-F9BE-4E92-816F-D76B819D0F02 @default.
- Q99563531 P304 Q99563531-F2E07BB8-1C47-400B-A2F4-33F5DD8EA3A6 @default.
- Q99563531 P31 Q99563531-3DF5766E-63EB-4C78-863F-BA411EBC94F4 @default.
- Q99563531 P356 Q99563531-5F577DD7-607B-4966-9F40-8858026588B6 @default.
- Q99563531 P433 Q99563531-451C227F-19E1-4ADA-86EF-0AF5B6F86582 @default.
- Q99563531 P478 Q99563531-BE8E8940-9781-4A6E-BF77-091E659A2ABF @default.
- Q99563531 P577 Q99563531-4D9719B1-F343-4FA4-96E4-54F7CAC58C2D @default.
- Q99563531 P698 Q99563531-CFBAD51D-E332-484A-9EEE-326195C55364 @default.
- Q99563531 P921 Q99563531-E353CC35-F2B7-45C8-9989-C54E44439AE3 @default.
- Q99563531 P356 S13075-020-02311-Y @default.
- Q99563531 P698 32943098 @default.
- Q99563531 P1433 Q15757229 @default.
- Q99563531 P1476 "Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trial" @default.
- Q99563531 P2093 "Alexandre Bleibtreu" @default.
- Q99563531 P2093 "Antoinette Perlat" @default.
- Q99563531 P2093 "Arsene Mekinian" @default.
- Q99563531 P2093 "Bertrand Lioger" @default.
- Q99563531 P2093 "David Saadoun" @default.
- Q99563531 P2093 "Eric Vicaut" @default.
- Q99563531 P2093 "French Takayasu network" @default.
- Q99563531 P2093 "Isabelle Quiere" @default.
- Q99563531 P2093 "Jacques-Eric Gottenberg" @default.
- Q99563531 P2093 "Jean Pierre Bertola" @default.
- Q99563531 P2093 "Jerome Connault" @default.
- Q99563531 P2093 "Juliette Delforge" @default.
- Q99563531 P2093 "Léa Savey" @default.
- Q99563531 P2093 "Matthieu Vautier" @default.
- Q99563531 P2093 "Nicolas Limal" @default.
- Q99563531 P2093 "Nicole Ferreira-Maldent" @default.
- Q99563531 P2093 "Olivier Fain" @default.
- Q99563531 P2093 "Patrice Cacoub" @default.
- Q99563531 P2093 "Patrick Jego" @default.
- Q99563531 P2093 "Pauline Lhorte" @default.
- Q99563531 P2093 "Sara Thietart" @default.
- Q99563531 P2093 "Zohra Talib" @default.
- Q99563531 P304 "218" @default.
- Q99563531 P31 Q13442814 @default.
- Q99563531 P356 "10.1186/S13075-020-02311-Y" @default.
- Q99563531 P433 "1" @default.
- Q99563531 P478 "22" @default.
- Q99563531 P577 "2020-09-17T00:00:00Z" @default.
- Q99563531 P698 "32943098" @default.
- Q99563531 P921 Q425154 @default.